With Every Patient
For 16 years, we’ve helped Sponsors design and execute value-driven programs that create broader treatment access opportunities for patients around the world.
With deep therapeutic understanding and a commitment to patient-centric drug development, we are experts at navigating regulatory complexities and managing the end-to-end operation of an access program. We help you evaluate the benefits and opportunities of providing access, while ensuring a clear understanding of the appropriate pathways to do so in a compliant manner. We create bespoke solutions and assemble purpose-built teams to help you achieve your goals.
Our Core Services
Expanded Access Programs
Helping Sponsors provide investigational drugs to patients outside the clinical trial setting, to fulfil unmet clinical needs
Post-Trial Access Programs
Allows Sponsors to provide access to their investigational drugs for patients after the clinical trial has ended.
Post-Approval Named Patient Programs
Helping Sponsors provide approved drugs to patients living in countries where they are not registered or commercially available
Market Access Strategic Consulting
Discovering opportunities to maximize the potential of your product and ensure commercial success in new markets
Adjacent Services
01
Project Management
Our PMs integrate seamlessly with your team, offering customized solutions, data-driven decisions, expert oversight, and seamless execution.
02
Real World Data
We work closely with Sponsors to understand the opportunity for Real World Data collection within their access programs.
03
Pharmacovigilance
Through our in-house expertise and capabilities, we can provide pharmacovigilance services for your programs.
pharmaceutical services provider
Global Reach With Local Knowledge
The WEP team has comprehensive regulatory and shipping knowledge, resulting in true global project management and distribution capabilities for our customers. WEP possess all the necessary licenses to allow us to source, handle, store and distribute pharmaceutical drugs and controlled substances in the US, EU and ROW. All of our activities are conducted under the strict guidelines of GCP, GDP and GMP, and we have a robust set of SOPs that guide all company processes and procedures.
HELPING A SPONSOR PROVIDE ACCESS TO INVESTIGATIONAL DRUG OUTSIDE OF CLINICAL TRIAL
Expanded Access